His primary areas of study are Radiation therapy, Internal medicine, Oncology, Surgery and Radiosurgery. His Radiation therapy study integrates concerns from other disciplines, such as Lung cancer, Randomized controlled trial, Metastasis and Nuclear medicine. His Internal medicine study frequently links to related topics such as Glioma.
His study in Oncology is interdisciplinary in nature, drawing from both Clinical trial, Multivariate analysis, Retrospective cohort study, Temozolomide and Neurocognitive. His Surgery research is multidisciplinary, incorporating perspectives in Hippocampal formation and Cancer. His work carried out in the field of Radiosurgery brings together such families of science as Brain metastasis, Survival rate, Combined Modality Therapy, Salvage therapy and Performance status.
Minesh P. Mehta spends much of his time researching Internal medicine, Oncology, Radiation therapy, Surgery and Nuclear medicine. In general Internal medicine study, his work on Temozolomide, Clinical trial and Chemotherapy often relates to the realm of In patient, thereby connecting several areas of interest. His Oncology research incorporates elements of Glioma, Neurocognitive, Newly diagnosed and Phases of clinical research.
The Radiation therapy study combines topics in areas such as Cancer, Lung cancer and Randomized controlled trial. His research in Surgery intersects with topics in Metastasis and Incidence. In Nuclear medicine, Minesh P. Mehta works on issues like Tomotherapy, which are connected to Medical physics.
Internal medicine, Oncology, Radiation therapy, Radiology and Radiosurgery are his primary areas of study. His work in the fields of Internal medicine, such as Temozolomide and Clinical trial, intersects with other areas such as In patient. His work is dedicated to discovering how Clinical trial, Hazard ratio are connected with Proportional hazards model and other disciplines.
His Oncology research includes themes of Newly diagnosed, Clinical endpoint, Cohort and Phases of clinical research. His Radiation therapy study is associated with Surgery. Minesh P. Mehta studied Radiosurgery and Metis that intersect with INFRATENTORIAL BRAIN.
Minesh P. Mehta mainly focuses on Internal medicine, Oncology, Radiation therapy, Clinical trial and Glioblastoma. His Internal medicine study frequently draws connections between adjacent fields such as Surgery. His Surgery research is multidisciplinary, relying on both Adverse effect and Esophageal cancer.
His Oncology study combines topics from a wide range of disciplines, such as Toxicity, Proportional hazards model, Retrospective cohort study and Hazard ratio. His Radiation therapy research integrates issues from Randomized controlled trial and Disease. His research integrates issues of Tumor progression, Meningioma, Intermediate risk and Intensive care medicine in his study of Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial
David W Andrews;Charles B Scott;Paul W Sperduto;Adam E Flanders.
The Lancet (2004)
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Mark R. Gilbert;James J. Dignam;Terri S. Armstrong;Terri S. Armstrong;Jeffrey Scott Wefel.
The New England Journal of Medicine (2014)
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Paul W. Sperduto;Norbert Kased;David Roberge;Zhiyuan Xu.
Journal of Clinical Oncology (2012)
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
Gregory Cairncross;Meihua Wang;Edward Shaw;Robert Jenkins.
Journal of Clinical Oncology (2013)
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Paul W. Sperduto;Brian Berkey;Laurie E. Gaspar;Minesh Mehta.
International Journal of Radiation Oncology Biology Physics (2008)
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
Vinai Gondi;Stephanie L. Pugh;Wolfgang A. Tome;Chip Caine.
Journal of Clinical Oncology (2014)
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Paul W. Sperduto;Samuel T. Chao;Penny K. Sneed;Xianghua Luo.
International Journal of Radiation Oncology Biology Physics (2009)
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
Monika E. Hegi;Lili Liu;James G. Herman;Roger Stupp.
Journal of Clinical Oncology (2008)
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
Mark R. Gilbert;Meihua Wang;Kenneth D. Aldape;Roger Stupp.
Journal of Clinical Oncology (2013)
American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy.
Louis Potters;Brian Kavanagh;James M. Galvin;James M. Hevezi.
International Journal of Radiation Oncology Biology Physics (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: